PAVmed
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $5 | $6 | $8 |
Gross Profit | -50 | -35 | -71 |
EBITDA | -5,981 | -12,298 | 18,670 |
EBIT | -6,003 | -12,320 | 18,627 |
Net Income | -5,383 | -11,921 | 18,968 |
Net Change In Cash | 5 | 6 | 8 |
Free Cash Flow | -899 | -1,186 | -1,587 |
Cash | 3,103 | 4,004 | 2,700 |
Basic Shares | 718 | 602 | 1,749 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $71,000 | $2,995 | $2,452 | $377 |
Gross Profit | -147,000 | -3,043 | -3,968 | -3,237 |
EBITDA | -21,806,000 | 29,670 | -75,742 | -99,500 |
EBIT | 28,472 | -78,674 | -101,957 | |
Net Income | -3,774,000 | 39,791 | -64,175 | -88,983 |
Net Change In Cash | 71,000 | 2,995 | 2,452 | 377 |
Free Cash Flow | -5,206,000 | -33,609 | -52,278 | -72,525 |
Cash | 1,538,000 | 1,185 | 19,639 | 39,744 |
Basic Shares | 670 | 2,176 | 241 | 197 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.60 |
2025-06-30 | -$0.74 |
2025-03-31 | -$0.07 |
2024-12-31 | -$0.19 |
